AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
MOMETASONE FUROATE in Zimbabwe
2 products registered with MCAZ — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MOMATE NASAL SPRAY SPRAY, METERED; NASAL | 2025/20.2.2/6932 | GLENMARK PHARMACEUTICAL LIMITED | active | 28 Apr 2030 |
| NASEHALER SUSPENSION | 2016/20.2.2/5292 | CIPLA LTD | active | 31 Dec 2027 |
MOMETASONE FUROATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 2 registered products containing MOMETASONE FUROATE, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track MOMETASONE FUROATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.